VC-backed Cytek Biosciences goes public

Cytek Biosciences, a cell analysis solutions company, has raised $200 million for its IPO after pricing its nearly 7 million shares at $17 per share.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this